Lung Cancer In Kentucky
Improving Patient Outcomes
Interactive online learning for primary care providers
Kentucky leads the nation in lung cancer incidence and mortality rates, which are closely tied to the state's high adult smoking prevalence. Fortunately, recent years have brought new recommendations and insurance coverage for lung cancer screening, advances in lung cancer treatment, and growing survivorship resources. Given Kentucky's heavy lung cancer burden, concerted efforts are warranted to ensure that these improvements in care reach all at-risk Kentuckians. Primary care providers can play an important role in this effort. "Lung Cancer in Kentucky: Improving Patient Outcomes" educates primary care providers in Kentucky on ways to improve lung cancer care across the continuum. This online continuing education offering was developed by Kentucky Cancer Program at the University of Louisville - as part of the statewide Kentucky LEADS (Lung Cancer Education, Awareness, Detection, and Survivorship) Collaborative. It addresses lung cancer prevention through tobacco cessation, lung cancer screening with low-dose computed tomography (LDCT), shared decision-making, enhancing treatment through collaboration with specialists, and lung cancer survivorship after diagnosis. This interactive and engaging program consists of four lessons that can be completed in individual segments.
This course is designed for physicians, physician assistants, and nurse practitioners who practice in primary care settings in Kentucky.
Other providers are welcome to participate as well.
Physician Credit-The University of Louisville Continuing Medical Education office designates this enduring material for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians and physician assistants should claim only the credit commensurate with the extent of their participation in the activity. A minimum aggregate score of 80 percent on all post-tests is required in order to claim CME credit.
Nurse Practitioner Credit: This activity is approved for 2.0 contact hours of continuing education by the American Association of Nurse Practitioners. Program ID 16072241. This activity was planned in accordance with AANP Accreditation Standards and Policies.
The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity was planned in accordance with AANP Accreditation Standards and Policies.
The course takes approximately 1.0 - 2.5 hours. During the course you will watch narrated informational screens, video interviews, shared decision making demonstrations, and view course materials.
You must register, create a user profile, and take a pre-activity questionnaire before you are able to view the course and access the Resource Library. Once each lesson has been completed, you will take a post-test, followed by overall course evaluations, after which you will be able to generate your CME certificate. You will be able to stop the course at any point and resume later if you wish.
At the end of the session the participant should be able to demonstrate the following knowledge and/or skills:
No commercial support was used or received to fund this online course.
Connie Sorrell has received funding for contracted research from Bristol-Myers Squibb Foundation. Ms. Sorrell's contributions to the content of this course have been peer reviewed by Dr. Daniel Cogan and are determined to be free of commercial bias. Dr. Cogan has no relevant financial relationships with any commercial bias.
Celeste Worth has no relevant financial relationships with any commercial interests.
Planning Committee Members
Ruth Mattingly, Morel Jones, and Kristin Paul, APRN have no relevant financial relationships with any commercial interests.
Celeste Worth, Ruth Mattingly, Morel Jones, Brigitte Danielle King, and Barry Brian Sosnin have no relevant financial relationships with any commercial interests. Dr. Goetz Kloecker has received speaker fees from Lilly, Bristol-Myers Squibb, Celgene, Genentech, and Boehringer Ingelheim, and consulting fees from Lilly and Novartis. Dr. Kloecker's presentation has been peer reviewed by Dr. Daniel Cogan and is determined to be free of commercial bias. Dr. Cogan has no relevant financial relationships with any commercial bias.
CME & PD Staff and Advisory Board
The CME & PD staff and Advisory Board have nothing to disclose.
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact Morel Jones at firstname.lastname@example.org.
If you need support or have any questions related to obtaining CME credit, please e-mail the University of Louisville Continuing Medical Education and Professional Development program at email@example.com
If you have any questions about the content of this course or need assistance, please email us at firstname.lastname@example.org.
All information provided by course participants is confidential and will not be shared with any other parties for any reason without permission.
The University of Louisville has obtained permission from the Kentucky Cancer Program to use the content in this educational activity. If you would like to share content from this training/program, please contact Morel Jones at the Kentucky Cancer Program (email@example.com.).